GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Dongkook Pharmaceutical Co 086450.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

23,350

-0.85%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

6 analysts, 1 Apr 2026. The analysts' own views, not ours.

  • 2Strong buy
  • 3Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 25 Mar 2026. Not our view.

Average target 28,050

Low
25,250
Average
28,050
Median
28,050
High
31,500

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029
Revenue₩1.04trn₩1.18trn₩1.33trn₩1.42trn
Revenue, highest₩1.04trn₩1.20trn₩1.35trn₩1.44trn
Revenue, lowest₩1.03trn₩1.15trn₩1.32trn₩1.40trn
Earnings per share1892.652184.752595.50—
Earnings per share, highest1954.282364.362640.39—
Earnings per share, lowest1831.022005.142550.61—
Analysts2211

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

8 / 10

Revenue growth 13.6% a year over 10 years. Return on equity 9.9%.

Model fair value

21,249.82

From earnings 21,249.82, from revenue 20,125.48.

Piotroski score

6 / 9

A nine-point test of financial strength, for 31 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.